TROKENDI XR 25 MG CAPSULE

topiramate
$12.3502per EA

Strength

25 mg/1

NDC

17772010130

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

TOPIRAMATE

Approval Type

New Drug (NDA)

FDA Application

NDA201635

On Market Since

8/16/2013

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

-0.0%

3M

-0.6%

6M

-0.6%

1Y

+5.1%

3Y

+4.9%

5Y

+17.6%

All

+56.5%